Nghiên cứu hóa thực vật và hoạt tính sinh học của ba loài Schisandra Trung Quốc (Schisandra sphenanthera, Schisandra henryi và Schisandra rubriflora): những phát hiện hiện tại và ứng dụng trong tương lai

Bensky D, Gamble A (1993) Chinese herbal medicine materia medica. Eastland Press, Vista Bi H, Li F, Krausz KW et al (2013) Targeted metabolomics of serum acylcarnitines evaluates hepatoprotective effect of Wuzhi tablet (Schisandra sphenanthera extract) against acute acetaminophen toxicity. Evid Based Complement Altern Med. https://doi.org/10.1155/2013/985257 Březinová L, Vlašínová H, Havel L et al (2010) Validated method for bioactive lignans in Schisandra chinensis in vitro cultures using a solid phase extraction and a monolithic column application. Biomed Chromatogr 24:954–960. https://doi.org/10.1002/bmc.1391 Casarin E, Dall’Acqua S, Šmejkal K et al (2014) Molecular mechanisms of antiproliferative effects induced by Schisandra-derived dibenzocyclooctadiene lignans (+)-deoxyschisandrin and (−)-gomisin N in human tumour cell lines. Fitoterapia 98:241–247. https://doi.org/10.1016/j.fitote.2014.08.001 Chang J, Reiner J, Xie J (2005) Progress on the chemistry of dibenzocyclooctadiene lignans. Chem Rev 105:4581–4609. https://doi.org/10.1021/cr050531b Chen Y-G, Wu Z-C, Lv Y-P et al (2003) Triterpenoids from Schisandra henryi with cytotoxic effect on leukemia and Hela cells in vitro. Arch Pharm Res 26:912–916. https://doi.org/10.1007/BF02980199 Chen YG, Wu ZC, Gui SH et al (2005) Lignans from Schisandra henryi with DNA cleaving activity and cytotoxic effect on leukemia and Hela cells in vitro. Fitoterapia 76:370–373. https://doi.org/10.1016/j.fitote.2005.03.012 Chen M, Kilgore N, Lee KH, Chen DF (2006) Rubrisandrins A and B, lignans and related anti-HIV compounds from Schisandra rubriflora. J Nat Prod 69:1697–1701. https://doi.org/10.1021/np060239e Chen Y, Zhang Y, Liu Y et al (2010) A new triterpenoid acid from Schisandra henryi. Chem Natl Compd 46:480–481 Chen Y, Tang J, Wang X et al (2012) An immunostimulatory polysaccharide (SCP-IIa) from the fruit of Schisandra chinensis (Turcz.) Baill. Int J Biol Macromol 50:844–848. https://doi.org/10.1016/j.ijbiomac.2011.11.015 Chen YC, Liaw CC, Bin Cheng Y et al (2013) Anti-liver fibrotic lignans from the fruits of Schisandra arisanensis and Schisandra sphenanthera. Bioorgan Med Chem Lett 23:880–885. https://doi.org/10.1016/j.bmcl.2012.11.040 Chinese Pharmacopoeia Commission (2005) Pharmacopoeia of the People’s Republic of China. China Chemical Industry Press, Beijing Chiu PY, Lam PY, Yan CW, Ko KM (2011) Schisandrin B protects against solar irradiation-induced oxidative injury in BJ human fibroblasts. Fitoterapia 82:682–691. https://doi.org/10.1016/j.fitote.2011.02.010 Christophe W (2013) Lead compounds from medicinal plants for the treatment of cancer, 1st edn. Elsevier, London Connolly JD, Hill RA (2010) Triterpenoids. Nat Prod Rep 27:79–132. https://doi.org/10.1039/B808530G Denk T, Oh IC (2005) Phylogeny of Schisandraceae based on morphological data: evidence from modern plants and the fossil record. Plant Syst Evol 256:113–145. https://doi.org/10.1007/s00606-005-0327-3 European Directorate for the Quality of Medicines (2013) Schisandra fruit. In: European Pharmacopoeia 8.0. Strasburg, p 1381 European Directorate for the Quality of Medicines (2017) Schisandra fruit. In: European Pharmacopoeia 9.0. Strasburg, p 1514 European Food Safety Authority (2010) Panel on dietetic products, nutrition and allergies 1489 Fan X, Jiang Y, Wang Y et al (2014) Wuzhi tablet (Schisandra sphenanthera extract) protects against acetaminophen-induced hepatotoxicity by inhibition of CYP-mediated bioactivation and regulation of NRF2-ARE and p53/p21 pathways. Drug Metab Dispos 42:1982–1990. https://doi.org/10.1124/dmd.114.059535 Fil’kin AM (1952) About Schizandra chinensis (historical-literary information). Aptechnojje Delo 2:46–48 Garnier S, Msika P (2013) Schisandra sphenanthera fruit extract and cosmetic, dermatological, and nutraceutical compositions comprising same (Patent) Garnier S, Naaimi D, Baudouin C (2012) Cosmetic composition for the treatment of acne comprising a peptide extract of Schizandra (Patent) Georgiev V, Schumann A, Pavlov A, Bley T (2014) Temporary immersion systems in plant biotechnology. Eng Life Sci 14:607–621. https://doi.org/10.1002/elsc.201300166 Gottlieb OR (1972) Chemosystematics of the Lauraceae. Phytochemistry 11:1537–1570. https://doi.org/10.1016/0031-9422(72)85001-5 Hancke J, Burgos R, Wikman G et al (1994) Schizandra chinensis, a potential phytodrug for recovery of sport horses. Fitoterapia 65:113–118 Hancke JL, Burgos RA, Ahumada F (1999) Schisandra chinensis (Turcz.) Baill. Fitoterapia 70:451–471. https://doi.org/10.1016/S0367-326X(99)00102-1 He F, Pu JX, Huang SX et al (2010) Schinalactone A, a new cytotoxic triterpenoid from Schisandra sphenanthera. Org Lett 12:1208–1211. https://doi.org/10.1021/ol902974j Hernandez DE, Hancke JL, Wikman G (1988) Evaluation of the anti-ulcer and antisecretory activity of extracts of Aralia elata root and Schizandra chinensis fruit in the rat. J Ethnopharmacol 23:109–114. https://doi.org/10.1016/0378-8741(88)90120-1 Hu D, Yang Z, Yao X et al (2014) Dibenzocyclooctadiene lignans from Schisandra chinensis and their inhibitory activity on NO production in lipopolysaccharide-activated microglia cells. Phytochemistry 104:72–78. https://doi.org/10.1016/j.phytochem.2014.04.014 Huang SX, Bin Han Q, Lei C et al (2008) Isolation and characterization of miscellaneous terpenoids of Schisandra chinensis. Tetrahedron 64:4260–4267. https://doi.org/10.1016/j.tet.2008.02.085 Huang HC, Lin YC, Fazary AE et al (2011) New and bioactive lignans from the fruits of Schisandra sphenanthera. Food Chem 128:348–357. https://doi.org/10.1016/j.foodchem.2011.03.030 Huyke C, Engel K, Simon-Haarhaus B et al (2007) Composition and biological activity of different extracts from Schisandra sphenanthera and Schisandra chinensis. Planta Med 73:1116–1126. https://doi.org/10.1055/s-2007-981559 Hwang SY, Lee YJ, Lee YK et al (2009) Gomisin N isolated from Schisandra chinensis significantly induces anti-proliferative and pro-apoptotic effects in hepatic carcinoma. Mol Med Rep 2:725–732. https://doi.org/10.3892/mmr_00000163 Hwang D, Shin SY, Lee Y et al (2011) A compound isolated from Schisandra chinensis induces apoptosis. Bioorgan Med Chem Lett 21:6054–6057. https://doi.org/10.1016/j.bmcl.2011.08.065 Iu HL, Li-jia XU, Eng YP et al (2009) Two new lignans from Schisandra henryi. Chem Pharm Bull 57:405–407. https://doi.org/10.1248/cpb.57.405 Jiang K, Song QY, Peng SJ et al (2015) New lignans from the roots of Schisandra sphenanthera. Fitoterapia 103:63–70. https://doi.org/10.1016/j.fitote.2015.03.015 Jin J, Bi H, Hu J et al (2011) Effect of Wuzhi tablet (Schisandra sphenanthera extract) on the pharmacokinetics of paclitaxel in rats. Phyther Res 25:1250–1253. https://doi.org/10.1002/ptr.3407 Ko KM, Mak DH, Li PC et al (1995) Enhancement of hepatic glutathione regeneration capacity by a lignan-enriched extract of fructus Schisandrae in rats. Jpn J Pharmacol 69:439–442 Kochetkov NK, Khorlin A, Chizhov OS, Sheichenko VI (1961) Schizandrin—lignan of unusual structure. Tetrahedron Lett 2:730–734. https://doi.org/10.1016/S0040-4039(01)91684-3 Kohda H, Ozaki M, Namera A (2012) Production of lignans in calluses of Schisandra chinensis. J Nat Med 66:373–376. https://doi.org/10.1007/s11418-011-0586-y Korea Food and Drug Administration (2002) Korean Pharmacopoeia. Seoul Li L, Ren H, Yang X et al (2004a) Rubriflorin A and B, two novel partially saturated dibenzocyclooctene lignans from Schisandra rubriflora 19 species, mostly growing in the southwestern part of the country on mountains 1500 m. Helv Chim Acta. 87:3–7 Li L, Ren HY, Yang XD et al (2004b) Rubriflorin A and B, two novel partially saturated dibenzocyclooctene lignans from Schisandra rubriflora. Helv Chim Acta 87:2943–2947. https://doi.org/10.1002/hlca.200490265 Li R, Shen Y, Xiang W, Sun H (2004c) Four novel nortriterpenoids isolated from Schisandra henryi var. yunnanensis. Eur J Org Chem. https://doi.org/10.1002/ejoc.200300560 Li GP, Zhao JF, Tu YQ et al (2005) Chemical constituents of Schisandra rubriflora Rehd. et Wils. J Integr Plant Biol 47:362–367. https://doi.org/10.1111/j.1744-7909.2005.00085.x Li HM, Luo YM, Pu JX et al (2008) Four new dibenzocyclooctadiene lignans from Schisandra rubriflora. Helv Chim Acta 91:1053–1062. https://doi.org/10.1002/hlca.200890113 Liang C, Hu J, Shi Y et al (2013) Schisphenlignans A–E: five new dibenzocyclooctadiene lignans from Schisandra sphenanthera. Chem Pharm Bull 61:96–100 Liu CS, Fang SD, Huang MF et al (1978) Studies on the active principles of Schisandra sphenanthera Rehd. et Wils. The structures of schisantherin A, B, C, D, E, and the related compounds. Sci Sin 21:483–502 Liu JS, Huang MF, Ayer WA, Nakashima TT (1984) Structure of enshicine from Schisandra henryi. Phytochemistry 23:1143–1145. https://doi.org/10.1016/S0031-9422(00)82627-8 Liu J-S, Tao Y, Huang M-F (1988) Studies on the constituents of Schisandra henryi. V. The structures of wulignan A1, A2, epiwulignan A1 and epischisandrone. J Chin Chem Soc 46:483–488 Liu H, Zhang J, Li X et al (2012) Chemical analysis of twelve lignans in the fruit of Schisandra sphenanthera by HPLC–PAD-MS. Phytomedicine 19:1234–1241. https://doi.org/10.1016/j.phymed.2012.07.017 Lu Y, Chen DF (2009) Analysis of Schisandra chinensis and Schisandra sphenanthera. J Chromatogr A 1216:1980–1990. https://doi.org/10.1016/j.chroma.2008.09.070 Lu H, Liu GT (1991) Effect of dibenzo[a,c]cyclooctene lignans isolated from Fructus Schizandrae on lipid peroxidation and anti-oxidative enzyme activity. Chem Biol Interact 78:77–84. https://doi.org/10.1016/0009-2797(91)90104-F Ma J, Chikwamba R, Sparrow P et al (2005) Plant-derived pharmaceuticals—the road forward. Trends Plant Sci 10:580–585. https://doi.org/10.1016/j.tplants.2005.10.009 Miao M, Gao J, Zhang G et al (2009) Effect of Schisandra chinensis polysaccharide on intracerebral acetylcholinesterase and monoamine neurotransmitters in a d-galactose-induced aging brain mouse model. Neural Regen Res 4:687–693. https://doi.org/10.3969/j.issn.1673-5374.2009.09.009 Mu H-X, Li X-S, Fan P et al (2011) Dibenzocyclooctadiene lignans from the fruits of Schisandra rubriflora and their anti-HIV-1 activities. J Asian Nat Prod Res 13:393–399. https://doi.org/10.1080/10286020.2011.565748 Murashige T, Skoog F (1962) A revised medium for rapid growth and bioassays with tobacco tissue cultures. Physiol Plant 15:473–479 Opletal L, Sovová H, Bártlová M (2004) Dibenzo[a, c]cyclooctadiene lignans of the genus Schisandra: importance, isolation and determination. J Chromatogr B 812:357–371. https://doi.org/10.1016/j.jchromb.2004.07.040 Panero JL, Aranda PD (1998) The family Schisandraceae: a new record for the flora of Mexico. Brittonia 50:87. https://doi.org/10.2307/2807721 Panossian A, Wikman G (2008) Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine. J Ethnopharmacol 118:183–212. https://doi.org/10.1016/j.jep.2008.04.020 Peng Y, Duan SM, Wang YW (2015) Concise synthesis of the DEFG ring system in rubriflordilactone B. Tetrahedron Lett 56:4509–4511. https://doi.org/10.1016/j.tetlet.2015.05.117 Qin XL, Bi HC, Wang CX et al (2010a) Study of the effect of Wuzhi tablet (Schisandra sphenanthera extract) on tacrolimus tissue distribution in rat by liquid chromatography tandem mass spectrometry method. Biomed Chromatogr 24:399–405. https://doi.org/10.1002/bmc.1305 Qin XL, Bi HC, Wang XD et al (2010b) Mechanistic understanding of the different effects of Wuzhi tablet (Schisandra sphenanthera extract) on the absorption and first-pass intestinal and hepatic metabolism of Tacrolimus (FK506). Int J Pharm 389:114–121. https://doi.org/10.1016/j.ijpharm.2010.01.025 Ren R, Luo GJ, Li HM et al (2009) Schisanlactone G, a new 3,4-seco-lanostane triterpenoid from Schisandra sphenanthera. Chin Chem Lett 20:601–603. https://doi.org/10.1016/j.cclet.2008.12.053 Ren R, Ci XX, Li HZ et al (2010) New dibenzocyclooctadiene lignans from Schisandra sphenanthera and their proinflammatory cytokine inhibitory activities. Zeitschrift für Naturforsch Sect B J Chem Sci 65:211–218 Saunders RMK (ed) (2000) Monograph of Schisandra (Schisandraceae). In: Systematic botany monographs. American Society of Plant Taxonomists, pp 1–146. http://www.jstor.org/stable/25027879 Schneider M, Windbergs M, Daum N et al (2013) Crossing biological barriers for advanced drug delivery. Eur J Pharm Biopharm 84:239–241. https://doi.org/10.1016/j.ejpb.2013.03.009 Shi P, He Q, Zhang Y et al (2009) Characterisation and identification of isomeric dibenzocyclooctadiene lignans from Schisandra chinensis by high-performance liquid chromatography combined with electrospray ionisation tandem mass spectrometry. Phytochem Anal 20:197–206. https://doi.org/10.1002/pca.1115 Shi Y-M, Li X-Y, Li X-N et al (2011) Schicagenins A–C: three cagelike nortriterpenoids from leaves and stems of Schisandra chinensis. Org Lett 13:3848–3851. https://doi.org/10.1021/ol201366d Shuwei L, Haodong C (2000) On the indications of bifendate. Advers Drug React J 2:225–228 Sun Y, Wen X, Huang H (2010) Population genetic differentiation of Schisandra chinensis and Schisandra sphenanthera as revealed by ISSR analysis. Biochem Syst Ecol 38:257–263. https://doi.org/10.1016/j.bse.2010.01.005 Szopa A, Ekiert H (2012) In vitro cultures of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine)—a potential biotechnological rich source of therapeutically important phenolic acids. Appl Biochem Biotechnol 166:1941–1948. https://doi.org/10.1007/s12010-012-9622-y Szopa A, Ekiert H (2016) The importance of applied light quality on the production of lignans and phenolic acids in Schisandra chinensis (Turcz.) Baill. cultures in vitro. Plant Cell Tissue Organ Cult 127:115–121. https://doi.org/10.1007/s11240-016-1034-1 Szopa A, Klimek M, Ekiert H (2016a) Chinese magnolia vine (Schisandra chinensis)—therapeutic and cosmetic importance. Pol J Cosmetol 19:274–284 Szopa A, Kokotkiewicz A, Marzec-Wróblewska U et al (2016b) Accumulation of dibenzocyclooctadiene lignans in agar cultures and in stationary and agitated liquid cultures of Schisandra chinensis (Turcz.) Baill. Appl Microbiol Biotechnol 100:3965–3977. https://doi.org/10.1007/s00253-015-7230-9 Szopa A, Ekiert R, Ekiert H (2017a) Current knowledge of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine) as a medicinal plant species: a review on the bioactive components, pharmacological properties, analytical and biotechnological studies. Phytochem Rev 16:195–218. https://doi.org/10.1007/s11101-016-9470-4 Szopa A, Kokotkiewicz A, Luczkiewicz M, Ekiert H (2017b) Schisandra lignans production regulated by different bioreactor type. J Biotechnol 247:11–17. https://doi.org/10.1016/j.jbiotec.2017.02.007 Szopa A, Kokotkiewicz A, Król A et al (2018) Improved production of dibenzocyclooctadiene lignans in the elicited microshoot cultures of Schisandra chinensis (Chinese magnolia vine). Appl Microbiol Biotechnol 102:945–959. https://doi.org/10.1007/s00253-017-8640-7 Thandavarayan RA, Giridharan VV, Arumugam S et al (2015) Schisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK/p53 signaling. PLoS ONE 10:e0119214. https://doi.org/10.1371/journal.pone.0119214 Umezawa T (2003) Diversity in lignan biosynthesis. Phytochem Rev 2:371–390. https://doi.org/10.1023/B:PHYT.0000045487.02836.32 Upton R, Graff A, Jolliffe G et al (2011) American herbal pharmacopoeia: botanical pharmacognosy—microscopic characterization of botanical medicines. CRC Press, Boca Raton Verpoorte R, Contin A, Memelink J (2002) Biotechnology for the production of plant secondary metabolites. Phytochem Rev 1:13–25. https://doi.org/10.1023/A:1015871916833 Waiwut P, Shin M-S, Yokoyama S et al (2012) Gomisin A enhances tumor necrosis factor-α-induced G1 cell cycle arrest via signal transducer and activator of transcription 1-mediated phosphorylation of retinoblastoma protein. Biol Pharm Bull 35:1997–2003 Walsh G (2002) Biopharmaceuticals and biotechnology medicines: an issue of nomenclature. Eur J Pharm Sci 15:135–138. https://doi.org/10.1016/S0928-0987(01)00222-6 Walsh G (2003) Pharmaceutical biotechnology products approved within the European Union. Eur J Pharm Biopharm 55:3–10. https://doi.org/10.1016/S0939-6411(02)00165-0 Wang HJ, Chen YY (1985) Studies of lignans from Schisandra rubriflora Rhed et Wils. Acta Pharm Sin 20:832–841 Wang QY, Deng LL, Liu JJ et al (2015) Schisanhenol derivatives and their biological evaluation against tobacco mosaic virus (TMV). Fitoterapia 101:117–124. https://doi.org/10.1016/j.fitote.2015.01.006 Wei H, Sun L, Tai Z et al (2010) A simple and sensitive HPLC method for the simultaneous determination of eight bioactive components and fingerprint analysis of Schisandra sphenanthera. Anal Chim Acta 662:97–104. https://doi.org/10.1016/j.aca.2009.12.039 Whiting DA (1985) Lignans and neolignans. Nat Prod Rep 193:191–211 Whiting DA (1990) Lignans, neolignans, and related compounds. Nat Prod Rep 7:349–364. https://doi.org/10.1039/np9900700349 World Health Organization (2007) WHO monographs on selected medicinal plants, vol 3. Fructus Schisandrae, Geneva Wu Z, Raven P, Hong DY (2008) Flora of China, vol 7. Science Press and Missouri Botanical Garden Press, Beijing, St. Louis Xiao W-L, Yang L-M, Gong N-B et al (2006a) Rubriflordilactones A and B, two novel bisnortriterpenoids from Schisandra rubriflora and their biological activities. Org Lett 8:991–994. https://doi.org/10.1021/ol060062f Xiao WL, Pu JX, Chang Y et al (2006b) Sphenadilactones A and B, two novel nortriterpenoids from Schisandra sphenanthera. Org Lett 8:1475–1478. https://doi.org/10.1021/ol060324d Xiao WL, Pu JX, Wang RR et al (2007a) Isolation and structure elucidation of nortriterpenoids from Schisandra rubriflora. Helv Chim Acta 90:1505–1513. https://doi.org/10.1002/hlca.200790157 Xiao WL, Wang RR, Zhao W et al (2007b) Triterpenoids from Schisandra rubriflora. J Nat Prod 33:1056–1059. https://doi.org/10.1007/s12272-010-0508-7 Xiao WL, Yang LM, Li LM et al (2007c) Sphenalactones A–D, a new class of highly oxygenated trinortriterpenoids from Schisandra sphenanthera. Tetrahedron Lett 48:5543–5546. https://doi.org/10.1016/j.tetlet.2007.05.152 Xiao W-L, Li R-T, Huang S-X et al (2008a) Triterpenoids from the Schisandraceae family. Nat Prod Rep 25:871. https://doi.org/10.1039/b719905h Xiao WL, Huang SX, Wang RR et al (2008b) Nortriterpenoids and lignans from Schisandra sphenanthera. Phytochemistry 69:2862–2866. https://doi.org/10.1016/j.phytochem.2008.09.010 Xiao W-L, Wu Y-L, Shang S-Z et al (2010a) Four new nortriterpenoids from Schisandra lancifolia. Helv Chim Acta 93:1975–1982. https://doi.org/10.1002/hlca.201000004 Xiao W, Yang S-Y, Yang L-M et al (2010b) Chemical constituents from the leaves and stems of Schisandra rubriflora. J Nat Prod 73:221–225. https://doi.org/10.1021/np900849y Xiao WL, Wang RR, Zhao W et al (2010c) Anti-HIV-1 activity of lignans from the fruits of Schisandra rubriflora. Arch Pharm Res 33:697–701. https://doi.org/10.1007/s12272-010-0508-7 Xie Y, Hao H, Kang A et al (2010) Integral pharmacokinetics of multiple lignan components in normal, CCl4-induced hepatic injury and hepatoprotective agents pretreated rats and correlations with hepatic injury biomarkers. J Ethnopharmacol 131:290–299. https://doi.org/10.1016/j.jep.2010.06.038 Xue Y-B, Zhang Y-L, Yang J-H et al (2010) Nortriterpenoids and lignans from the fruit of Schisandra chinensis. Chem Pharm Bull 58:1606–1611. https://doi.org/10.1248/cpb.58.1606 Xue YB, Yang JH, Li XN et al (2011) Henrischinins A–C: three new triterpenoids from Schisandra henryi. Org Lett 13:1564–1567. https://doi.org/10.1021/ol200283y Xue XP, Qin XL, Xu C et al (2013) Effect of Wuzhi tablet (Schisandra sphenanthera extract) on the pharmacokinetics of cyclosporin A in rats. Phyther Res 27:1255–1259. https://doi.org/10.1002/ptr.4849 Yasukawa K, Ikeya Y, Mitsuhashi H et al (1992) Gomisin A inhibits tumor promotion by 12-O-tetra-decanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Oncology 49:68–71. https://doi.org/10.1159/000227014 Zhou Y, Huang S-X, Pu J-X et al (2011) Ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometric procedure for qualitative and quantitative analyses of nortriterpenoids and lignans in the genus Schisandra. J Pharm Biomed Anal 56:916–927. https://doi.org/10.1016/j.jpba.2011.07.045 Zhu M, Yeung RY, Lin KF, Li RC (2000) Improvement of phase I drug metabolism with Schisandra chinensis against CCl4 hepatotoxicity in a rat model. Planta Med 66:521–525. https://doi.org/10.1055/s-2000-11202 Zhu M, Chen XS, Wang KX (2007) Variation of the lignan content of Schisandra chinensis (Turcz.) Baill. and Schisandra sphenanthera Rehd. et Wils. Chromatographia 66:125–128. https://doi.org/10.1365/s10337-007-0261-3